CLSI AUTO16
Next-Generation In Vitro Diagnostic Instrument Interface, 1st Edition, AUTO16Ed1E
standard by Clinical and Laboratory Standards Institute, 04/23/2019
NACE ASAE-ASABE B11 CGA ICC CTA
Next-Generation In Vitro Diagnostic Instrument Interface, 1st Edition, AUTO16Ed1E
standard by Clinical and Laboratory Standards Institute, 04/23/2019
Specimen Labels: Content and Location, Fonts, and Label Orientation; Approved Standard, AUTO12AE
standard by Clinical and Laboratory Standards Institute, 04/01/2011
Analysis and Presentation of Cumulative Antimicrobial Susceptibility Test Data; Approved Guideline–Fourth Edition, M39A4E
standard by Clinical and Laboratory Standards Institute, 01/01/2014
Newborn Screening by Tandem Mass Spectrometry, NBS04Ed2E
standard by Clinical and Laboratory Standards Institute, 05/01/2017
Use of Glucose Meters for Critically Ill Patients, 1st Edition, POCT17Ed1E
standard by Clinical and Laboratory Standards Institute, 03/29/2016
Glucose Monitoring in Settings Without Laboratory Support; Approved Guideline, POCT13Ed3E
standard by Clinical and Laboratory Standards Institute, 06/01/2015
Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Fourth Informational Supplement, M27S4
standard by Clinical and Laboratory Standards Institute, 12/01/2012
Newborn Screening for Cystic Fibrosis; Approved Guideline (Formerly I/LA35-A), NBS05AE
standard by Clinical and Laboratory Standards Institute,
Method for Antifungal Disk Diffusion Susceptibility Testing of Filamentous Fungi; Approved Guideline, M51A
standard by Clinical and Laboratory Standards Institute, 01/01/2010
Procedures for Validation of INR and Local Calibration of PT/INR Systems; Approved Guideline, H54-A
standard by Clinical and Laboratory Standards Institute, 08/19/2005
Analysis of Body Fluids in Clinical Chemistry; Approved Guideline, C49AE
standard by Clinical and Laboratory Standards Institute, 04/01/2007